Skip to content
← Back to this collection

PUBLICATIONS · 11157476

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2001 Feb 1
First author
Moskowitz CH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Moskowitz CH
      type
      Author
    2. name
      Nimer SD
      type
      Author
    3. name
      Zelenetz AD
      type
      Author
    4. name
      Trippett T
      type
      Author
    5. name
      Hedrick EE
      type
      Author
    6. name
      Filippa DA
      type
      Author
    7. name
      Louie D
      type
      Author
    8. name
      Gonzales M
      type
      Author
    9. name
      Walits J
      type
      Author
    10. name
      Coady-Lyons N
      type
      Author
    11. name
      Qin J
      type
      Author
    12. name
      Frank R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Moskowitz CH
      type
      Author
    2. name
      Nimer SD
      type
      Author
    3. name
      Zelenetz AD
      type
      Author
    4. name
      Trippett T
      type
      Author
    5. name
      Hedrick EE
      type
      Author
    6. name
      Filippa DA
      type
      Author
    7. name
      Louie D
      type
      Author
    8. name
      Gonzales M
      type
      Author
    9. name
      Walits J
      type
      Author
    10. name
      Coady-Lyons N
      type
      Author
    11. name
      Qin J
      type
      Author
    12. name
      Frank R
      type
      Author
    bibliography ids
    1. nci-bib-293df98bb5e320b57704c820
    book metadata
    content sha256
    0124117ce54e342d528659251243b99d8daf5c17c06b4cef23908ef16520643d
    document type
    citation
    dois
    1. 10.1182/blood.v97.3.616
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11157476
    immutable id
    pubmed:11157476@0124117ce54e342d528659251243b99d8daf5c17c06b4cef23908ef16520643d
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    3
    name
    Blood
    nlm unique id
    7603509
    pages
    616-23
    volume
    97
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11157476
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      51840fef3e4cdefe9dec68dc7a4cc6f50b4d55ce73d347ef2903e2c56b1b198f
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Feb 1
      precision
      day
      year
      2001
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      4. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11157476/
      title
      A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

      Preserved source evidence · Not medical advice